10-K: Ingevity Navigates Strategic Shifts, Reports 2025 Losses

Ingevity Corporation finalized its strategic portfolio review in 2025, divesting its industrial specialties and CTO refinery businesses, while reporting a net loss of $167.1 million for the year, impacted by significant impairment charges and legal expenses.

Summary

• Completed a Strategic Portfolio Review, leading to a refocused 'New Ingevity' comprised of Performance Materials and Pavement Technologies segments.
• Divested the North Charleston crude tall oil (CTO) refinery and the majority of the Performance Chemicals industrial specialties product line, with the sale completed on January 1, 2026.
• Exploring strategic alternatives for the Advanced Polymer Technologies (APT) segment and the Performance Chemicals road markings product line, expected to be completed by the end of 2026.
• Reported a net loss of $167.1 million for the fiscal year 2025, an improvement from the $430.3 million net loss in 2024, but still a significant loss compared to a $5.4 million net loss in 2023.
• Incurred a non-cash goodwill impairment charge of $183.8 million for the APT segment in Q2 2025 due to global trade tensions and weak industrial demand.
• Recorded a non-cash long-lived asset impairment charge of $109.3 million for the Performance Chemicals road markings asset group in Q4 2025.
• The U.S. Federal Circuit Court of Appeals ruled against Ingevity on February 11, 2026, in the BASF patent infringement appeal, with payment of the $85.0 million trebled jury verdict plus post-judgment interest (totaling $95.4 million as of December 31, 2025) expected in Q2 2026.
• Net sales decreased to $1,167.6 million in 2025 from $1,200.1 million in 2024, primarily driven by the APT segment.
• Adjusted EBITDA (Non-GAAP) increased to $397.5 million in 2025 from $362.7 million in 2024.
• Repurchased $56.3 million of common stock (1,061,460 shares) in 2025, with $297.5 million remaining under the authorization.
• Incurred $8.2 million in proxy contest charges during 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging period marked by significant losses and asset impairments, despite strategic repositioning efforts. The ongoing legal liability and uncertain market conditions for some segments contribute to a cautious outlook.

Positives

• Adjusted EBITDA (Non-GAAP) increased to $397.5 million in 2025 from $362.7 million in 2024, indicating improved operational profitability excluding certain non-recurring items.
• Performance Materials segment maintained sales year-over-year at $606.9 million despite automotive industry disruptions, achieving a strong Segment EBITDA margin of 53.8%.
• Performance Chemicals Segment EBITDA increased to $60.3 million in 2025 from $53.7 million in 2024, supported by improved pricing, favorable mix, and lower raw material costs.
• The Pavement Technologies product line within Performance Chemicals showed slight volume growth in the NAFTA region, offsetting declines in South America.
• Advanced Polymer Technologies (APT) maintained strong EBITDA margins at 20.0% despite a sales decline, attributed to operational discipline and reduced operating expenses.
• Cash provided by operating activities significantly increased to $331.2 million in 2025 from $128.6 million in 2024.
• Successfully ratified a new Collective Bargaining Agreement (CBA) with the International Brotherhood of Electrical Workers (IBEW) at the Covington, Virginia Performance Materials plant on June 24, 2025.
• Achieved a 29% reduction in personal and process safety incidents in 2025 compared to 2024, demonstrating a strong commitment to health and safety.
• Earned ISO 27001 information security framework certification in 2024, enhancing cybersecurity posture.

Negatives

• Reported a net loss of $167.1 million in 2025, indicating continued unprofitability.
• Net sales decreased by $32.5 million in 2025, primarily due to a 15% volume decline in the Advanced Polymer Technologies (APT) segment.
• Incurred a significant non-cash goodwill impairment charge of $183.8 million for the APT segment in Q2 2025 due to global trade tensions and weak industrial demand.
• Recorded a non-cash long-lived asset impairment charge of $109.3 million for the Performance Chemicals road markings asset group in Q4 2025.
• The U.S. Federal Circuit Court of Appeals ruled against Ingevity in the BASF patent infringement appeal, resulting in an $85.0 million trebled damages judgment plus post-judgment interest (totaling $95.4 million accrued as of December 31, 2025), with payment expected in Q2 2026.
• Incurred $8.2 million in proxy contest charges during 2025.
• Gross profit was negatively impacted by a LIFO charge of $16.3 million in 2025.
• The effective tax rate was negatively impacted by a decrease in the foreign-derived intangible income deduction and a significant decrease in the Federal Research and Development credit in 2025 due to the One Big Beautiful Bill (OBBB) tax reform.
• The Performance Chemicals road markings product line experienced price pressure from competition.
• The Collective Bargaining Agreement (CBA) at the Covington, Virginia plant with the Covington Paperworkers Union Local 675 expired on December 1, 2025, with negotiations ongoing.

Risks

• The review of strategic alternatives for the Advanced Polymer Technologies (APT) segment and Performance Chemicals road markings product line may not result in a transaction or yield the expected results or benefits.
• Dependence on third parties for critical operating services at several plants (Covington, Virginia, and Warrington, United Kingdom) poses risks of disruptions or increased costs.
• Potential liability for 10% to 50% of costs and expenses related to wastewater treatment non-compliance at the Covington, Virginia paper mill, despite representing less than 3% of total wastewater volume.
• Disruptions at manufacturing plants due to natural disasters, labor difficulties, equipment failure, cyberattacks, or unscheduled maintenance could negatively impact production and financial results.
• Single-site manufacturing for certain products (extruded honeycomb, caprolactone, pavement preservation/construction/recycling products) limits redundancy.
• Raw material pricing pressures and limited availability for key inputs like hardwood sawdust, phosphoric acid, ethylene amines, tall oil fatty acid (TOFA), and lignin could impact operations or financial results.
• Disruptions within the supply chain and transportation network (truck, rail, barge, ship) due to factors like rail service interruptions, rising fuel costs, tariffs, and capacity constraints.
• Exposure to risks inherent in international sales and operations, including foreign currency exchange rate fluctuations, restrictions on cash repatriation, complex regulatory compliance, geopolitical instability, and changes in tariff regimes.
• Adverse conditions in the automotive market, such as shifts towards alternative energy vehicles (electric and hydrogen fuel cell vehicles), may negatively impact demand for automotive carbon products.
• The pavement technologies product line is heavily dependent on government infrastructure spending, making it vulnerable to reductions or delays in public funding.
• Competition from new technologies and emerging competitors, including alternative activated carbon products, sealed gas tanks, and other caprolactone manufacturers, could adversely affect market position and financial results.
• Inability to develop products for all-electric and hydrogen fuel cell vehicles or grow sales fast enough to offset the expected decline in activated carbon sales for internal combustion engines.
• Dependence on certain large customers (top ten customers accounted for 41% of total sales in 2025), with the loss of any major customer potentially having a material adverse effect.
• Inability to attract and retain key personnel, including production workers, engineering, technical, sales, and application specialists, could adversely affect financial condition and results of operations.
• Risks associated with future acquisitions and investments, including difficulties in integration and exposure to unknown liabilities.
• Cyber-attacks, data and privacy breaches, or failures of information technology systems could disrupt operations, expose the company to liability, and damage its reputation.
• Legal actions associated with intellectual property rights, such as the BASF lawsuit, could result in significant costs and diversion of resources.
• Reliance on unpatented proprietary technology, know-how, and trade secrets, which may be difficult to protect.
• Growth in the Performance Materials' automotive carbon business is dependent on the adoption of more stringent air quality standards worldwide, which may be delayed or shelved.
• Hazards associated with chemical manufacturing, storage, transportation, and disposal could lead to operational interruptions, personal injury, environmental damage, and legal liabilities.
• Changes in environmental laws and regulations, including climate change laws, could subject operations to significant additional capital expenditures and operating expenses.
• Failure to achieve sustainability goals or adequately respond to sustainability concerns could harm reputation and investor interest.
• Adverse weather conditions and other environmental impacts (e.g., climate change) may impact operations and demand for seasonal products like pavement technologies and road markings.
• General global economic and financial conditions, including inflation, rising interest rates, and changes in tax laws, could adversely affect financial results.
• Challenges in the commercial and credit environment may materially adversely affect access to capital.

Future Outlook

Ingevity expects net sales for 2026 to be between $1.1 billion and $1.2 billion. Performance Materials net sales are projected to grow low-single digits, driven by pricing offsetting a forecasted decline in global automotive production for internal combustion engine powertrains. Performance Chemicals net sales, including the road markings product line, are expected to grow mid-single digits due to continued adoption of warm mix asphalt products. Advanced Polymer Technologies net sales are anticipated to grow low-single digits, reflecting a mild recovery in industrial end markets. Adjusted EBITDA for 2026 is expected to be between $380 million and $400 million, with Performance Materials maintaining 2025 margins, Performance Chemicals achieving mid-teens margins (burdened by stranded costs), and APT improving EBITDA with margins around 20%. The company expects to fully eliminate $15 million of stranded costs from the divested industrial specialties product line over 2026, with $8 million to $12 million burdening the company in 2026, and full run rate savings achieved in 2027. The effective tax rate is expected to be between 22% and 24%, and Adjusted Earnings Per Share is projected to be between $4.80 and $5.20. Capital expenditures for 2026 are estimated at $40 million to $60 million, primarily for maintenance and safety, health, and environment projects.

Management Comments

• "New Ingevity's businesses will be focused on high-value, mission-critical applications that benefit from durable, long-term demand and will allow Ingevity to retain our global scale, maintain a strong pro forma financial profile, and provide a more stable, simplified specialty materials portfolio poised to deliver profitable growth with best-in-class earnings before interest, taxes, depreciation, and amortization ('EBITDA') margins."
• "We believe our two business segments are unified by very strong core competencies, including unique technologies that incorporate deep technical expertise on highly engineered materials, leading market positions, and intellectual property, all of which creates a sustainable competitive advantage for Ingevity."
• "The resilience of our Performance Materials business becomes more evident." (referring to maintaining sales despite automotive industry disruptions)
• "The team remained focused on operational discipline, which drove more reliable plant production and reduced operating expenses." (referring to Advanced Polymer Technologies)

Industry Context

StockSavvy.ai notes that Ingevity's strategic portfolio review and divestitures align with a broader industry trend of specialty chemical companies streamlining operations to focus on higher-margin, less cyclical businesses. The emphasis on 'New Ingevity' with Performance Materials and Pavement Technologies suggests a move towards more stable, high-value applications, while divesting industrial specialties and exploring alternatives for APT and road markings. The challenges faced by the APT segment due to global trade tensions and weak industrial demand, and the automotive carbon business's exposure to shifts towards electric vehicles, highlight the pressures on traditional chemical sectors to adapt to evolving market dynamics and sustainability trends.

Comparison to Industry Standards

• Ingevity's automotive activated carbon products are positioned as a low-risk choice for high-performance applications, achieving life-of-vehicle emission standards, competing with manufacturers like Norit and Kuraray Co., Ltd.
• In pavement technologies, Ingevity competes with Nouryon Chemicals B.V., Arkema S.A., and Zydex Group, differentiating through deep customer knowledge and expertise in road-building technologies.
• In road markings, primary competitors include Sherwin-Williams Company and PPG Industries Traffic Solutions, where Ingevity maintains a strong market position based on service, reliability, and consistent product performance.
• In the Advanced Polymer Technologies segment, Ingevity faces competition from other caprolactone manufacturers such as Daicel Corporation, Hunan Juren Chemical Hitechnology, and BASF SE, and differentiates through sustainability elements like high durability and biodegradability.

Management Changes

Corporate Governance

Legal Proceedings

• The U.S. Federal Circuit Court of Appeals ruled against Ingevity on February 11, 2026, regarding its appeal in the patent infringement lawsuit against BASF Corporation.
• Ingevity has decided to no longer pursue any further appeals in the BASF case.
• Payment of the $85.0 million trebled jury verdict, plus post-judgment interest (totaling $95.4 million as of December 31, 2025), is expected to be made in the second quarter of 2026.
• BASF has indicated it will seek attorneys' fees and costs in amounts to be determined at a future date.

Related Party Transactions

• The historical industrial specialties product line, now classified as discontinued operations, included indirect costs related to corporate and shared service functions that were previously allocated to it. These costs remain reported within continuing operations.
• Ingevity has historical agreements with WestRock Company and its affiliates, including the Amended and Restated Crude Tall Oil and Black Liquor Soap Skimmings Agreement, dated March 20, 2023, and an amendment dated November 1, 2023. These relate to the divested CTO refinery operations.

Stakeholder Impact

• Shareholders: Experienced negative impact from net losses, significant impairment charges, and a substantial legal judgment. The stock repurchase program provides some capital return, but the stock performance has lagged broader market and chemical industry indices over the past five years.
• Employees: Positive impact from the ratification of a new CBA with IBEW. However, ongoing negotiations with the Covington Paperworkers Union Local 675 introduce some uncertainty. The company's focus on health and safety, evidenced by a 29% reduction in incidents, benefits the workforce. Management changes indicate strategic adjustments at the executive level.
• Customers: Customers in the Performance Materials and Pavement Technologies segments may benefit from the company's strategic focus on high-value, mission-critical applications. Customers of the Advanced Polymer Technologies segment face weak industrial demand and increased competition. The divestiture of the industrial specialties product line may impact customers previously served by that segment.
• Suppliers: The company faces risks related to raw material availability and pricing pressures, which could affect supplier relationships and costs.
• Creditors: The company's debt levels and compliance with financial covenants are important. The plan to amend and extend the revolving credit facility aims to maintain financial flexibility.

Next Steps

• Complete the exploration of strategic alternatives for the Advanced Polymer Technologies (APT) segment and the Performance Chemicals road markings product line by the end of 2026.
• Make payment of the BASF judgment plus post-judgment interest in the second quarter of 2026.
• Amend and extend the existing revolving credit facility before the end of the second quarter of 2026.
• Continue contract renewal negotiations with the Covington Paperworkers Union Local 675.
• Incur approximately $10 million of additional cash charges during 2026 related to the Performance Chemicals Repositioning Actions.
• Achieve the full run rate from stranded cost savings in 2027.
• Execute projected 2026 capital expenditures of $40 million to $60 million, primarily for maintenance and safety, health, and environment projects.
• Prioritize reducing injuries related to slips, trips, and falls in 2026.

Key Dates

Recommendation

Ingevity is undergoing a significant strategic transformation, divesting non-core assets and focusing on higher-margin businesses. While the 2025 financial results show substantial losses due to impairment charges and a major legal settlement, the underlying operational performance in core segments like Performance Materials remains resilient. The future outlook for 'New Ingevity' projects modest growth and stable margins. However, the ongoing legal liabilities, the uncertainty of completing further divestitures, and the need to fully eliminate stranded costs present near-term headwinds. A 'Hold' recommendation reflects the company's transitional phase, with potential for long-term value creation from the streamlined portfolio, balanced against current financial challenges and execution risks.

Keywords

Ingevity, NGVT, Annual Report, 10-K, Specialty Chemicals, Performance Materials, Performance Chemicals, Advanced Polymer Technologies, Strategic Review, Divestiture, Impairment, Net Loss, Adjusted EBITDA, Automotive Carbon, Pavement Technologies, Road Markings, Caprolactone, BASF Lawsuit, Share Repurchase, Corporate Governance, Risk Factors, Financial Performance, Outlook 2026, Sustainability